Invictus MD Strategies Corp. (
TSX: V.IMH, :
OTCQB: IVTF,
Forum) on Friday announced the sale of its first 120 kilograms of dried flower from AB Laboratories Inc. to
Canopy Growth Corp. (
TSX: T.WEED,
Forum), putting Invictus MD’s license holders on track to achieving 26,000 kilograms of run rate production capacity for 2018 with net capacity of 22,150 kilograms to Invictus MD.
AB Labs maintains a 16,000-square-foot licensed production facility in Hamilton, Ont. The facility is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
Additionally, the company said it has signed the definitive agreement to make its further strategic investment in AB Labs, from its current 33.3 per cent ownership interest to 50 per cent.
More information can be found
here.
Invictus was in the news recently when it
announced the acquisition of a 33% stake in AB Laboratories. which maintains a 16,000-square-foot facility in Hamilton. AB Labs is working to increase its production capacity through AV Ventures Inc. which recently acquired 100 acres in Ontario, land that will be used for the construction of five new production facilities.
Full Disclosure: Invictus MD Strategies Corp. is a paid client of Stockhouse Publishing.